Contrast-enhancing agents for demonstrating abnormalities of the blood-brain barrier may extend the diagnostic utility of proton nuclear magnetic resonance (NMR) imaging. "TES," a nitroxide stable free radical derivative, was tested as a central nervous system contrast enhancer in dogs with experimentally induced unilateral cerebritis or radiation cerebral damage. After intravenous injection of TES, the normal brain showed no change in NMR appearance, but areas of disease demonstrated a dramatic increase (up to 45%) in spin-echo intensity and a decrease in Ti relaxation times. The areas of disease defined by TES enhancement were either not evident on the nonenhanced NMR images or were better defined after contrast administration. In-depth tests of toxicity, stability, and metabolism of this promising NMR contrast agent are now in progress.Contrast-enhancing pharmaceutical agents may extend the diagnostic capa bilities of nuclear magnetic resonance (NMR) imaging. Paramagnetic substances tested as NMR contrast agents include the ions of manganese and iron and nitroxide stable free radicals (NSFRs) [1,2]; all have been shown to decrease proton relaxation times, namely T, and T2 [3]. Thus, paramagnetic substances enhance contrast differences between those tissues containing the contrast agent and magnetically similar tissues without it.In separate reports we have described the relative advantages and disadvan tages of various methods to manipulate NMR contrast [2,4] and the potential to directly evaluate renal function in experimental animals using NSFRs as uro graphy NMR contrast agents [2,5].NSFRs are a group of synthetic, strongly paramagnetic organic compounds that for two decades have been used as "spin labels" for in vitro biologic studies[6], A water-soluble piperidinyl NSFR derivative, "TES," is rapidly excreted into the urine after intravenous administration, an excretion pattern useful for NMR urographic studies [2,5]. TES demonstrates additional properties suggesting promise as a clinically useful NMR contrast agent; these include chemical stability of solutions over a broad range of pH and temperature, limited in vivo metabolism, and broad chemical versatility [2,6]. The ability to chemically attach TES to a variety of biomolecules, drugs, and particles may permit the synthesis of tissuespecific NMR contrast agents. Preliminary toxicity studies of NSFRs, the subject of future reports, are also favorable for the continued development of NSFRs as pharmaceuticals.In this study we examined the potential of TES to enhance NMR contrast within the brains of animals having experimentally induced cerebritis or radiation damage. Living dogs were imaged by NMR before and after intravenous admin istration of TES. Loci of brain injury were more clearly identified on the postcontrast images; TES appears to cross the blood-brain barrier (BBB) only at sites of disease and thereby increases the diagnostic yield from the NMR imaging examination.
Brain Nuclear Magnetic
Materials and Methods
Experimental AnimalsAlpha-strep...